Epigenetic study provides new approaches to combination therapies for aggressive cancers - Science Daily

Epigenetic study provides new approaches to combination therapies for aggressive cancers  Science Daily

A recent study reveals how the interaction of the epigenetic protein BRD4 with the metabolic enzyme MTHFD1 controls gene expression and cell proliferation.



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases